Articles 4 min read

Savvy Massachusetts Companies Receiving Outside Financing Should Consider This Tax Planning Opportunity Before Year-End

Massachusetts corporations receiving large cash infusions from equity investors may be surprised to find that the mere act of depositing the cash into their bank account can trigger thousands of dollars in excise taxes, whether they generate taxable income or not. Massachusetts Security Corporations (“MSCs”) can be used to solve this problem.

How Can My Company Owe Tax Without Any Income?

Massachusetts imposes a corporate tax consisting of two separate components:

This net worth excise tax frequently catches early stage and growth stage companies off guard—particularly those that raise capital late in the year.

Example

Assume the following scenario: ABC Corp. receives $10 million of outside equity financing during its first tax year. The company spends $1 million on deductible operating expenses. Year end balance sheet reflects $9 million of cash and $9 million of equity

Tax impact:

Total Massachusetts tax liability: $23,400

Surprised to find a company that incurs $1M in tax-deductible losses is subject to a tax bill in excess of $23,000? You are not alone.

Is There a Solution?

Yes. Companies expecting large “net worth” excise taxes should consider transferring cash to a wholly owned Massachusetts Security Corporation. This tax vehicle is not subject to the Massachusetts net worth tax. In our previous example, utilizing an MSC would have reduced ABC Corp’s tax liability from $23,400 to $456 (the minimum excise tax), resulting in almost $23,000 in tax savings!

How Do I Utilize a Massachusetts Security Corporation?

What’s the Catch?

Of course, tax planning is never simple and “one size does not fit all.” Additional requirements must be considered:

Companies that are interested in exploring this and other tax planning opportunities should contact a member of Withum’s professional team before year-end. Retroactive classifications are not allowed.

Withum plus signs

Have Questions or Need Guidance?

For more information on this topic, please contact a member of our team.

Contact Us

Related Insights

Read more
SEC-FDA Memorandum of Understanding (MOU)
A New Era of Regulatory Transparency: What Life Sciences Companies Should Know About the SEC-FDA’s New MOU

The SEC-FDA Memorandum of Understanding (MOU) signals more than interagency coordination. It reinforces the need for life sciences companies to align regulatory facts, investor communications, and disclosure controls with greater discipline. Here is why the agreement matters and how companies can respond proactively. On August 31, 2026, the U.S. Securities and Exchange Commission (SEC) and…

Read more
business man, cfo, in digital world
The C-Suite Spotlight: Stories of Growth and Strategy

Tune in to discover valuable insights into the world of financial leadership and learn the strategies these C-Suite executives use to ensure financial health and navigate the complexities of today’s business environment.

Read more
Artificial Hand Holding DNA Structure
Life Sciences, Artificial Intelligence and the R&D Tax Credit: Navigating Opportunity in a Rapidly Evolving Landscape

The life sciences industry has long been driven by innovation. From drug discovery and clinical development to advanced manufacturing and personalized medicine, life sciences companies continuously push the boundaries of science and technology. Today, artificial intelligence (AI) is accelerating that innovation cycle, creating new opportunities, and new considerations for companies seeking to benefit from the…